Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    According to the Graphical Research new growth forecast report titled Asia Pacific Bioreactors Market size is set to exceed USD 2.0 billion by 2026. The market is projected to foresee lucrative growth owing to adoption of technologically advanced equipment by pharmaceutical companies in the region. Rising demand for therapeutics due to increasing disease prone population has created the need for expansion of development and manufacturing capacities. The firms are focusing on strengthening production capabilities with integration of high yield equipment. Thus, demand for bioreactors offering improved product recovery will spur the overall market growth.

    The biopharmaceuticals industry in Asia is witnessing tremendous growth with improved favorable regulations, government support and enhanced funding scenario. For instance, Innovate in India program has been developed to accelerate biopharmaceutical discovery and research in collaboration with the Department of Biotechnology and World Bank. Such collaborative initiatives and efforts influencing the life sciences industry growth in the region will also boost the adoption of bioreactors in the upcoming period.

    However, concerns regarding limited volume capacity of single-use bioreactors and extractables, hampering the product quality and yield could impede the market growth up to some extent.

    Reusable bioreactors segment held over USD 590 revenue in 2019 and is estimated to witness momentous growth during analysis timeframe. Reusable systems are majorly preferred in commercial large-scale manufacturing due to its high capacity. Thus, huge demand for biopharmaceuticals lead to increasing adoption of reusable bioreactors. Also, increasing number of diseases affecting general population further contribute to pharmaceuticals, thereby impacting the demand.

    Yeast cells segment was valued over USD 25 million in 2019. Growing use of yeast cell culture in bioprocessing in biotechnology industries provides significant demand for bioreactors. Bioreactors enable high biomass concentration of cells that offers advantages such as cell reuse and high dilution rate during continuous process. Such benefits will contribute significant uptake of bioreactors in the Asia Pacific region.

    Recombinant proteins segment is forecasted to progress at 16.6% CAGR over period. Extensive applications of recombinant proteins from production to purification of biopharmaceutical boost product demand. Further, increase in clinical trials and approvals of recombinant proteins positively impact the segmental growth over analysis timeframe.

    Contract manufacturing organizations (CMOs) segment constituted more than 17% revenue share in 2019. Contract manufacturing provides cost advantage associated with production facility, thus maximizing the operating profit. Several manufactures are outsourcing production to improve their competency and productivity in the region. The benefits offered to the firms with limited infrastructure and resources will further spur adoption of bioreactors in CMOs over the forecast period.

    Japan bioreactors market is projected to proceed at 15.1% CAGR. Growing focus on stem cell research in the country will boost the adoption rate of bioreactors in the country. Also, substantial increase in geriatric population base has contributed to rising chronic disease burden. This has resulted into significant demand for effective treatment therapies and shifted focus towards gene therapy and stem cell research. Moreover, the preference for advanced technologies will impel Japan bioreactors industry growth potential.

    Major industry players involved in the market include Sartorius Group, Applikon Biotechnology Inc., Thermo Fisher Scientific, Merck Group, GEA Group Aktiengesellschaft, Cytiva (Danaher Group), and Eppendorf AG among others. These market players are undertaking strategies such as acquisitions and collaborations and product improvisations to increase the revenue and sustain the customer base in various geographical locations. For instance, in February 2020, Eppendorf announced the launch of SciVario twin bioreactor controller system for small bench-scale bioreactors. This has enabled remote monitoring of cell culture processes, thereby enhancing its product portfolio.

    Asia Pacific bioreactors market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2015 to 2026, for the following segments:

    Market Share, By Product Type, 2015-2026 (USD Million)

    • Single-use
    • Reusable

    Market Size, By Cell, 2015 – 2026 (USD Million)

    • Mammalian Cells
    • Bacterial Cells
    • Yeast Cells
    • Others

    Market Trends, By Molecule, 2015-2026 (USD Million)

    • Monoclonal Antibodies
    • Vaccines
    • Recombinant Proteins
    • Stem Cells
    • Gene Therapy
    • Others

    Market Forecast, By End-user, 2015-2026 (USD Million)

    • R&D organizations
    • Biopharmaceutical Manufacturers
    • Contract Manufacturing Organizations (CMOs)

    The above information is provided for the following region and countries:

    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Singapore
      • Indonesia
      • Malaysia
      • Philippines
      • Thailand
      • Others